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Abstract
Background: To examine transient environmental exposures and their relationship with human fecundity,
exposure assessment should occur optimally at the time of conception in both members of the couple.
We performed an observational, prospective cohort study with biomonitoring in both members of a heterosexual
couple trying to conceive. Couples collected urine, saliva, and semen specimens for up to two menstrual cycles on
days corresponding to the time windows of fertilization, implantation, and early pregnancy, identified based on the
woman’s observations of her cervical fluid.
Results: Three hundred nine eligible couples were screened between 2011 and 2015, of which 183 enrolled. Eleven
couples (6.0 %) withdrew or were lost to follow up. The most successful and cost effective recruiting strategies
were word of mouth (40 % of participating couples), posters and flyers (37 %), and targeted Facebook advertising
(13 %) with an overall investment of $37.35 spent on recruitment per couple. Both men and women collected ≥97.
2 % of requested saliva samples, and men collected ≥89.9 % of requested semen samples. Within the periovulatory
days (±3 days), there was at least one urine specimen collected by women in 97.1 % of cycles, and at least one by
men in 91.7 % of cycles. Daily compliance with periovulatory urine specimens ranged from 66.5 to 92.4 % for women
and from 55.7 to 75.0 % for men. Compliance was ≥88 % for questionnaire completion at specified time points.
Conclusions: Couples planning to conceive can be recruited successfully for periconceptional monitoring, and will
comply with intensive study protocols involving home collection of biospecimens and questionnaire data.
Keywords: Fecundity, Preconception, Endocrine disrupting chemicals, Ovulation, Semen, Research participant
recruitment
Background
A growing body of evidence suggests that environmental
exposures during the sensitive windows of the periconcep-
tional period are of concern for the reproductive health of
mother and embryo [1–3]. Related research demonstrates
that environmental contamination by endocrine disrupt-
ing chemicals during the fetal period affects virtually all
organ systems in fetal development and throughout sub-
sequent life [4–6]. Transient exposures may have
critical influences on fertility, spontaneous abortion,
and embryonic development, but limitations in expos-
ure assessment hamper our ability to understand these
effects. To monitor transient exposures at or near the
time of conception, the time of ovulation must be
identified prospectively and targeted exposure assess-
ment must occur during the relevant developmental
windows [7–9].
Conception (fertilization in vivo) is a highly-timed,
couple-based process [10]. A prospective design that
follows couples longitudinally beginning prior to concep-
tion and through a pregnancy or pregnancy loss, although
methodologically challenging, allows the investigator to
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capture exposure data during the time-sensitive fertile
window and to understand the temporal ordering between
exposures and outcomes [8, 11, 12]. Home collection of
data and biological specimens by study participants can
minimize participant burden while still assessing exposure
during the most time-sensitive periods of the fertile win-
dow, ovulation, and implantation [13, 14]. Women’s self-
observation of cervical fluid patterns has been repeatedly
validated as an effective approach for identifying the ap-
proach and timing of ovulation [15–17] (i.e., the fertile
window [18, 19]), but this approach has not been applied
to studies assessing environmental exposures in couples
trying to conceive.
We designed and successfully implemented a pro-
spective pregnancy study with home-based collection of
data and biological specimens to achieve several aims:
(1) conduct prospective, periovulational biomonitoring
in a preconception cohort using a novel strategy of self-
collection of biological specimens timed according to
women’s observation of their own fertility signs among
couples with normal fertility; (2) evaluate the association
between prospectively measured male and female envir-
onmental exposures (primarily bisphenol-A (BPA) and
disinfection-by-products) and semen quality and time to
pregnancy; and (3) quantify the degree of misclassifica-
tion bias generated by retrospective exposure assessment
methods in common use (participant self-report of past
exposure using a recall questionnaire and/or archival en-
vironmental monitoring data) compared to concurrent
periovulational biomonitoring and report of exposures.
This paper addresses our first aim and describes design
and implementation of the study protocol. We assess the
methodological soundness of our approach by evaluating
recruitment, cost of recruitment, eligibility, enrollment,
and compliance with collection of appropriately timed
biospecimens.
Methods
Study design, eligibility, and recruitment
The Home Observation of Periconceptional Exposures
(HOPE) study is an observational, prospective cohort study
designed to accomplish home-collected, individual-level
biomonitoring among heterosexual couples during the
sensitive windows of conception, implantation, and very
early pregnancy. The University of Utah Institutional
Review Board approved the study and written informed
consent was obtained from all participants prior to enroll-
ment. Couples were recruited and followed for up to
12 months between 2011 and 2015. Screening was con-
ducted with an online questionnaire (Qualtrics, Provo,
Utah, USA) with each member of the couple individually
screened to ensure that s/he met eligibility criteria. The
inclusion criteria were ages 18–35 for women, ages 18–40
for men, both in a heterosexual relationship, and planning
to start trying to conceive within three months of study
enrollment. Couples needed to reside within one hour of
the study office and be able to respond to study question-
naires and instructions in English. Female exclusion cri-
teria included fewer than nine menstrual flows in the
previous twelve months (unless due to breastfeeding or
use of an intrauterine device (IUD) with a subsequent re-
turn to normal menses); use of implantable hormonal
contraception in the previous two months; use of inject-
able medroxyprogesterone acetate (Depo-Provera®) in the
last twelve months. Women were also excluded if they
had previously performed daily tracking of cervical fluid
but had been unable to identify ovulation due to observa-
tions of continuous fluid, no fluid, or unchanging fluid
patterns. Couples were excluded if either member of the
couple had a previous diagnoses of infertility, subfertility,
or a condition that might affect fertility such as diagnosed
polycystic ovary syndrome (PCOS) or endometriosis with-
out a subsequent pregnancy among women, and low
sperm count among men, or had ever been unsuccessful
in conceiving a child after a year or more of regular sexual
intercourse without contraception. Our recruitment goal
was 300 couples, which we estimated would be a feasible
target while providing opportunity to detect variation in
time to pregnancy.
Several strategies were implemented to recruit partici-
pant couples, including newspaper advertisements, flyers
placed around the community and on university and col-
lege campuses, targeted Facebook advertising, targeted
Google AdWords advertising, campus-wide email list-
servs, and word of mouth. The online screening ques-
tionnaire included a question to determine recruitment
method for each inquiring individual. Participants were
encouraged to refer friends to the study and were com-
pensated $10 for every referred couple successfully en-
rolled up to three referrals.
Couples who met the inclusion criteria and con-
sented to participate met with a member of the study
staff for an in-person enrollment that took place at the
couple’s convenience either in their home, or in a
mutually convenient location with sufficient privacy.
During enrollment the study staff explained the study
procedures, demonstrated use of the online data entry
system, explained the daily fertility charting, obtained
height and weight measurements, collected hair snips,
and explained or demonstrated techniques for home
collection of biospecimens. Throughout the study,
staff communicated with couples on an individualized
basis, via their preferred method (e.g. phone, text, or
email).
Daily fertility chart
The timeline of study procedures for each participating
couple was based around the woman’s observations of
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her fertile window and menstrual cycle, as displayed in
Fig. 1. The enrollment visit was conducted during ap-
proximately the first ten days of the menstrual cycle, and
women were asked to start their daily fertility chart at
that time. This timing was designed to rule out pre-
existing pregnancy and to observe the estimated day of
ovulation or conception (EDO/C) for the first cycle in
most instances. This procedure was implemented early
in the study after three couples were enrolled when they
were found later to be already pregnant. Women were
taught daily fertility charting to identify ovulation and
the fertile window based on our previously validated ap-
proach, the Peak Day Method [20], a simplified method
for observing and recording “highly fertile” cervical fluid
observed externally as a vaginal discharge, with basal
body temperature. The initial appearance of one or more
of the “highly fertile” cervical fluid characteristics (clear,
stretchy, and/or slippery fluid) was used to identify pro-
spectively the beginning of the fertile window and the
approach of the EDO/C. The fertility chart also included
daily assessment of lifestyle exposures including inter-
course, medications, tobacco, alcohol, caffeine, stress,
and illness. Women were asked to record these
exposures daily for the entire cycle and men recorded
the same exposures daily during the fertile window.
Completed fertility charts were either picked up by a
member of the study staff or returned by mail using a
pre-paid return envelope.
Active and passive observation periods
The active observation period began in the first cycle
after enrollment in which the couples planned to try to
conceive and continued for up to two menstrual cycles
in which the couple continued to report intention to
conceive and an EDO/C was observed. If the couple did
not achieve pregnancy within the first two active obser-
vation cycles, fertility charting (including the daily
exposure questions) continued until the completion of
Fig. 1 Timeline of study procedures and time-varying data collection. aMean time between online screening and online consent was 9.5 ± 19.2 days
(Range 0–163). bMean time between online consent and enrollment was 9.9 ± 11.7 days (Range 0–68). cMean time between enrollment visit and onset
of fertile window was 9.8 ± 13.7 days (Range 0–76). dFirst day of fertile-quality cervical fluid observed by the woman marks the beginning of the fertile
window. ePeak Day of fertility according to Peak Day Algorithm (last day of best quality cervical fluid in mid-cycle). fIf pregnancy occurred in Cycle 1,
delivery estimated to take place at approximately the same time as Cycle 1 EDO/C + 38 weeks. If pregnancy occurred in Cycle 2, delivery estimated to
take place at approximately the same time as Cycle 2 EDO/C + 38 weeks. gThese two questionnaires were added to the study protocol with IRB
approval after recruitment began
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the passive observation period. For couples who con-
ceived in the first cycle of active observation, the end of
the passive observation period was Cycle 1 EDO/C +
38 weeks. For all other couples the end of the passive
observation period was Cycle 2 EDO/C + 38 weeks re-
gardless of pregnancy status.
Concurrent and retrospective online questionnaires
In addition to the exposure questions on the daily fertil-
ity charts, concurrent (once at EDO/C +2 days) and
retrospective (one time each at EDO/C + 18 days, EDO/
C + 6 weeks, and EDO/C + 38 weeks) online exposure
assessment questionnaires were completed related to the
first two complete cycles of active observation, or only
the first cycle if the couple conceived during Cycle 1.
Questionnaires were completed through a secure
response-interface (Qualtrics, Provo, Utah) and were de-
signed to assess exposure to food, water, and lifestyle
factors during the week of the EDO/C. The timing of
retrospective assessments were selected to correspond to
specific time points during pregnancy when early expos-
ure may be assessed: EDO/C + 18 days corresponds to
the day when a woman may notice delayed menses;
EDO/C + 6 weeks corresponds to when a woman may
have a first prenatal appointment (approximately 8 weeks
following her last menstrual period); EDO/C + 38 weeks
corresponds to when a woman would be expected to de-
liver a baby. However, questionnaires were administered
to everyone in the study, whether or not they became
pregnant within the active observation period (first two
cycles).
Women with live births resulting from conceptions
that occurred during the study were asked to complete
an additional questionnaire 3 weeks after the estimated
date of delivery to assess pregnancy outcomes, and to
provide medical release of information forms to allow
study staff to access the prenatal and obstetrical medical
records. Women who did not conceive during the study
were contacted six months after study completion and
asked to complete a questionnaire designed to ascertain
any pregnancy or medical treatment that may have oc-
curred beyond the study observation period [21].
Biospecimen collection
Participants were instructed to perform biospecimen
collection during the first two cycles of active observa-
tion. Men and women both were asked to collect daily
first-morning urine samples (first void upon waking)
from the first day of fertile-quality cervical fluid
throughout the fertile window until the EDO/C + 2 days.
Men were asked to discontinue collecting after EDO/C
+ 2 days (the end of the biologically relevant time period
for conception), and women were asked to continue to
collect for the remainder of the menstrual cycle until the
onset of the next menses or until she had a positive
home pregnancy test (QuickVue, Quidel, San Diego,
CA, USA) at EDO/C + 18 days. In cases where first-
morning samples were not collected, participants were
instructed to collect later in the day and mark the
specimen to indicate that it was not first-morning.
Urine was collected in four-ounce polypropylene spe-
cimen cups then transferred to 50 mL polypropylene
tubes that were placed in the participants’ home
freezer until the end of the menstrual cycle. At the
end of each cycle, a member of the study staff col-
lected the samples from the participants and trans-
ported them to the laboratory.
Both members of the couple completed a saliva speci-
men using a Quantisal Oral Fluid Collection Device
(Immunalysis, Pomona, CA, USA) on EDO/C + 2 days.
These specimens were retrieved by study staff at the end
of each cycle.
A semen sample from the man was collected at home
through intercourse after EDO/C + 2 days but before the
onset of menses of EDO/C + 18 days using a Male-
FactorPak™ semen collection device (Apex Medical
Technologies, Inc., San Diego, CA, USA) [22]. The
semen sample was frozen in the participant’s home
freezer and picked up by staff at the end of the cycle.
Abstinence prior to semen sample collection was not re-
quired but acts of intercourse were to be tracked on the
daily fertility chart.
Compensation
Couples were compensated up to $400 USD as follows:
$15/cycle for completion of two fertility charts and
EDO/C + 2 day questionnaires (women); $20/cycle for
semen samples and completion of the EDO/C + 2 day
questionnaire (men); $10/cycle/person for saliva sam-
ples; $20/cycle/person for urine samples; $7.50/cycle/
person for EDO/C + 18 day questionnaires; $12.50/
cycle/person for EDO/C + 6 week questionnaires; $15/
cycle/person for EDO/C + 38 week questionnaires;
$20/person study completion bonus; $10/couple for
acquaintance referral up to three. Couples who con-
ceived in the first cycle of study participation were
compensated what they would have received had they
participated in a second cycle to avoid any incentive
to delay conception in order to increase compensa-
tion [23].
Statistical analyses
Descriptive statistics were calculated to summarize co-
hort characteristics, biospecimen collection compliance,
and questionnaire completion using SAS software (SAS
version 9.4, SAS Institute, Inc., Cary, NC, USA).
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Results
One thousand fifty-two individuals (656 women, 396
men) completed the online screening questionnaire with
309 couples meeting the eligibility criteria (Fig. 2). Of
the eligible couples, 183 (59.2 %) enrolled, 38 (12.3 %)
subsequently declined to participate, and 88 (28.5 %) did
not respond to further communication. The most fre-
quent reasons for women being ineligible were being
previously being unable to conceive (54, 20.2 %), being
already pregnant (38, 14.2 %), using an implantable
contraceptive in the past two months (34, 12.7 %), or
because of a previous infertility or subfertility diagno-
ses (32, 12.0 %) (Table 1). When a man was ineligible
it was predominantly because his partner was ineli-
gible (56, 73.7 %). In cases where an individual was
initially ineligible at inquiry due to a reason that was
likely to change over time (i.e., not trying within
three months, implantable contraceptive within last
two months, fewer than nine menstrual flows due to
pregnancy or breastfeeding without subsequent return
to normal menses), the individual was asked if he or
she would like to be contacted again in the future by
study staff to reassess eligibility. Following the repeat
contact of 95 individuals, 30 were found to be eligible
and enrolled in the study, 16 were still ineligible, 8
declined to participate, and 41 did not respond.
Among couples who enrolled, the first member of the
couple to complete the screening was most frequently
the woman (n = 141, 77.0 %). A small proportion of
enrolled couples failed to complete the first two
Fig. 2 Screening, eligibility, enrollment, and biospecimen completion. aFour of the five couples withdrew due to changed pregnancy intentions
and one couple withdrew due to concerns about fertility. bAsked to leave the study due to uninterpretable cervical fluid without recognizable
estimated day of ovulation. cOne couple withdrew due to changed pregnancy intentions and the other due to stress
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cycles of active observation because they either with-
drew or were lost to follow-up (n = 11 couples, 6.0 %)
(Fig. 2).
Recruitment costs were assessed by comparing recruit-
ment yield obtained on enrollment questionnaires and
budget. Excluding word of mouth that occurred from
the spouse or partner, posters and flyers were the most
successful recruitment method for initiating screenings
(n = 246, 23.4 %), but not the most cost-efficient for en-
rollment ($51.58 per couple enrolled) (Table 2). Referrals
from friends or family were also successful in generating
screenings (n = 207, 19.7 %) and were the most cost-
efficient method ($10.00 per couple enrolled). Similarly
cost-efficient was targeted Facebook advertising (n = 167,
15.9 %) with a cost of $33.31 per enrolled couple. Direct
recruitment and advertising cost calculations were calcu-
lated for couples rather than individuals by restricting to
the index member of the couple (the first member of the
couple to complete a screening).
The mean age of female participants was 27.1 ±
3.6 years and of male participants was 28.5 ± 3.8 years
(Table 3). The majority of participants (318, 86.9 %) were
Caucasian and 23 (6.3 %) were Hispanic. Over half of men
(n = 109, 59.5 %) and over one-third (n = 69, 37.7 %) of
women were overweight or obese (BMI ≥ 25.0 kg/m2).
This population was highly educated with 60.4 % (221)
college graduates and 32.5 % (119) with some college edu-
cation (1–3 years). Over one-third of the cohort (n = 131,
35.8 %) had a household income between $40,000 and
Table 1 Reasons for initial ineligibility by sexa






Age 4 (5.3) 14 (5.2)
>1 h drive from Salt Lake City 1 (1.3) 0
Unable to respond to questionnaires in English 0 0
Not planning to conceive within 3 monthsc 3 (3.9) 32 (12.0)
Medroxy-progesterone acetate injection in last
12 months
NA 14 (5.2)
Implantable contraceptivebc NA 34 (12.7)
Fewer than 9 menstrual flows in the past yearc NA 29 (10.9)
Unable to conceive after a year of regular,
unprotected intercourse
6 (7.9) 54 (20.2)
Previous infertility or subfertility diagnosis 2 (2.6) 32 (12.0)
Continuous or indistinguishable cervical
mucus patterns in previous charting
NA 10 (3.8)
Separated from partner 1 (1.3) 1 (0.4)
Screening incomplete 3 (3.9) 1 (0.4)
Partner ineligible 56 (73.7) 8 (3.0)
Already pregnant NA 38 (14.2)
Abbreviations: NA (not applicable)
aEligibility assessed by online screening questionnaire
bImplanon® or intrauterine device
cIn these cases, individuals may have been contacted later to
reassess eligibility
Table 2 Efficiency and cost of recruitment by recruitment method











Spouse/Partner 313 (29.8) 254 (35.8) 149 (40.7) NA $0.00 $0.00
Friend/Relative 207 (19.7) 135 (19.0) 88 (24.0) 71 (38.8) $710.00d $10.00
Healthcare Professional 15 (1.4) 8 (1.1) 3 (0.8) 3 (1.6) $0.00 $0.00
Web/Email
Email or newsletter 43 (4.1) 25 (3.5) 8 (2.2) 8 (4.4) $0.00 $0.00
Facebook 167 (15.9) 95 (13.4) 25 (6.8) 24 (13.1) $799.44 $33.31
Webpage 28 (2.7) 13 (1.8) 5 (1.4) 5 (2.7) $0.00 $0.00
Google AdWords 2 (0.2) 0 0 0 $145.00 NA
Local news agency websitea 4 (0.4) 3 (0.4) 0 0 $1,000.00 NA
Televisionb 7 (0.7) 3 (0.4) 2 (0.5) 2 (1.1) $0.00 $0.00
Magazine/Newspaperc 12 (1.1) 7 (1.0) 3 (0.8) 3 (1.6) $706.00 $235.33
Posters/Flyers 246 (23.4) 166 (23.4) 83 (22.7) 67 (36.6) $3,474.18 $51.85
Total 1052 709 366 183 $6,834.62 $37.35
Eight screened respondents (0.8 % of total respondents) did not select a recruitment method and are not included in this table
Abbreviations: NA not applicable
aDeseret News
bPrincipal Investigator interviewed on local news
cUtah Family, Catalyst (local magazines)
dCost from compensation given to active participants for referrals
eThe index person is the initial member of the couple to complete a screening questionnaire
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$74,999 annually. Most participants were never smokers
(325, 88.8 %).
Compliance with collection of saliva and semen sam-
ples across both active cycles was as follows: women’s
saliva 280/286 = 97.9 %; men’s saliva 278/286 = 97.2 %;
semen 257/286 = 89.9 %. Compliance with collection of
daily urine samples was also high with specific metrics
for each cycle day from three days before to three days
after the EDO/C presented in Table 4. Among all active
cycles for which we have an identifiable EDO/C, a urine
specimen was collected on the EDO/C by the woman in
239 (86.6 %) cycles and by men in 208 (75.4 %) cycles.
For active cycles, 97.1 % had at least one urine sample
collected by women, and 91.7 % had at least one urine
sample collected by men within the perivoluatory days
(EDO/C ± 3 days).
Completion rates for concurrent and retrospective
questionnaires are reported in Table 5. Compliance was
≥88 % for all concurrent and retrospective online ques-
tionnaires. When stratified by sex, completion rates for
females ranged from 90 to 98 % and for males ranged
from 85 to 94 %. Fertility charts were collected for 623
(80.6 %) cycles.
Discussion
Our findings support a growing body of evidence that
both women and men planning pregnancy can be re-
cruited and will comply with protocols requiring the
collection of biospecimens and questionnaire data in
the periconception window [12, 13, 23–27]. Similar to
prior studies, the most common reasons for ineligibility
were having already become pregnant or subfertility,
highlighting the importance of rapid recruitment among
couples intending to conceive [23, 27, 28]. We successfully
enrolled 59.2 % of couples who screened eligible, a pro-
portion similar to other studies [13, 24, 27]. Participants
were self-selected volunteers and thus, no direct denomin-
ator is available for the target population at risk of or
planning pregnancy. Word of mouth referrals from
current participants (with modest recruitment incentives)
proved to be the most efficient recruitment tool. Targeted













Agea 27.7 ± 4.0 28.5 ± 3.8 27.1 ± 3.6
< 25 69 (18.9) 22 (12.0) 46 (25.1)
25–35 276 (75.4) 145 (79.2) 131 (71.6)
> 35 9 (2.5) 9 (4.9) 0
Missing 12 (3.3) 7 (3.8) 6 (3.3)
BMIb 26.1 ± 5.6 27.2 ± 5.8 24.9 ± 5.0
< 18.5 9 (2.5) 2 (1.1) 7 (3.8)
18.5–24.9 178 (48.6) 71 (38.8) 107 (58.5)
25.0–29.9 104 (28.4) 64 (34.9) 40 (21.9)
≥ 30 74 (20.2) 45 (24.6) 29 (15.8)
Missing 1 (0.3) 1 (0.6) 0
Race
Caucasian 318 (86.9) 156 (85.3) 162 (88.5)
Other/Multiracialc 40 (10.9) 23 (12.6) 17 (9.3)
Missing 8 (2.2) 4 (2.2) 4 (2.2)
Hispanic
Yes 23 (6.3) 12 (6.6) 11 (6.0)
No 334 (91.3) 166 (90.7) 168 (91.8)
Missing 9 (2.5) 5 (2.7) 4 (2.2)
Annual Incomed
< $20,000 44 (12.0) - -
$20,000–$39,000 109 (29.8) - -
$40,000–$74,999 131 (35.8) - -
$75,000–$99,000 39 (10.7) - -
≥ $100,000 26 (7.1) - -
Missing 17 (4.6) - -
Employment
Employed for wages 230 (62.8) 113 (61.8) 117 (63.9)
Self-employed 13 (3.6) 6 (3.3) 7 (3.8)
Homemaker 29 (7.9) 1 (0.6) 28 (15.3)
Student 77 (21.0) 54 (29.5) 23 (12.6)
Unemployed/Othere 7 (1.9) 4 (2.2) 3 (1.6)
Missing 10 (2.7) 5 (2.7) 5 (2.7)
Education
High School/GED 16 (4.4) 10 (5.5) 6 (3.3)
Some college
(1–3 years)
119 (32.5) 68 (37.2) 51 (27.9)
College
(>4 years, graduate)
221 (60.4) 100 (54.6) 121 (66.1)
Missing 10 (2.7) 5 (2.7) 5 (2.7)
Table 3 Characteristics of study participants (Continued)
Smoking
Never 325 (88.8) 156 (85.3) 169 (92.4)
Former 21 (5.7) 16 (8.7) 5 (2.7)
Current 6 (1.6) 5 (2.7) 1 (0.5)
Missing 14 (3.8) 6 (3.3) 8 (4.4)
Abbreviations: SD (standard deviation), BMI (body mass index)
aAge in years
bBody Mass Index: weight (kg)/height (m)2 (measured at enrollment)
cIncludes Asian, Black/African American, Pacific Islander, American
Indian/Alaskan Native
dUS Dollars, combined household income for both partners
eIncludes out of work, retired, unable to work
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Facebook ads, an innovative recruitment strategy, were
productive and highly cost-effective in our study, simi-
lar to another recent preconception enrollment study
[27]. Facebook allowed us to target our advertisement
to appear to select individuals based on marital status,
age, sex, and location. Posters and flyers generated
nearly one-quarter of our total screenings but were less
cost-effective. In terms of strategic planning for recruit-
ment, targeting women had a greater yield in generat-
ing screenings.
Participants in our study were predominantly white
and well educated. There was a low proportion of
current smokers (<2 %), and the mean age for women
was 27.1 years. While the lack of racial and ethnic diver-
sity may be a limitation, the absence of smoking allows
for less confounding in examining the impact of other
environmental and lifestyle exposures on reproductive
outcomes.
Retention of participants despite the intensive study
protocol was high with a dropout rate of only 6.0 % (11
couples). This rate is lower compared to reported rates
from other prospective cohorts of couples trying to
conceive in Denmark (8 %) [24], France (36 %) [29],
Michigan and Texas (26 % and 27.2 %, respectively) [13],
at four centers in the United States (12.2 %) [28],
through internet-based methods (19 %) [27], and at
seven European centers (25 %) [30], but higher than a
study in Washington, DC (4 %) [25]. We believe this
high retention rate was related to effective relationships
that study staff built with participant couples, flexibility
in communication, the convenience of home based
visits, and study compensation commensurate with the
level of intensity of data collection.
Compliance with collection of semen samples was
high over two cycles (89.9 %). Comparatively, 64 % of
monthly semen samples for up to six cycles were re-
ceived in Denmark [24], and the LIFE Study [31] reports
94 % compliance with semen collection at baseline and
77 % compliance with semen collection for a second
semen sample; both studies collected via masturbation.
Investigators may wish to consider the utility of home-
based collection of semen samples through intercourse
with semen collection devices to increase response rate,
depending on the cultural context; although study objec-
tives and analytical limitations of frozen specimens ver-
sus fresh specimens must be considered.
Comparison of compliance with collection of urine to
other preconception studies is difficult as study designs
vary widely. Bonde et al. [24] report 84 % compliance
with women submitting daily urine on days one through
ten of each menstrual cycle up to six cycles or until
pregnancy, and men with 59 % compliance in submitting
one to two pre- or post-shift urines monthly during
those cycles. Zinaman et al. [25] requested women to
submit daily morning urine samples for three cycles;
compliance was >90 %. Buck-Louis et al. [13] requested
three spot samples per woman with compliance ranging
from 77 to 100 %, and two spot urine samples per man
with compliance ranging from 94 to 100 %. Wilcox et al.
[26] reported 98 % compliance among 221 women col-
lecting daily samples for up to six months or until preg-
nancy. In this study, compliance with this collection
protocol on periovulatory days (EDO/C ± 3 days) ranged
from 67 to 94 % for women and from 56 to 75 % for
men. Because men must rely on communication from
Table 4 Urine collection completion relative to estimated day of ovulation with or without conception (EDO/C)
EDO/C-3a EDO/C-2a EDO/C-1a EDO/C EDO/C + 1 EDO/C + 2 EDO/C + 3
All Cycles
Female 124/185 (67.0) 175/234 (74.8) 216/262 (82.4) 239/276 (86.6) 249/276 (90.2) 258/276 (93.5) 257/276 (93.1)
Male 103/185 (55.7) 146/234 (62.4) 191/262 (72.9) 208/276 (75.4) 207/276 (75.0) 164/276 (59.4) 72/276 (26.1)b
Conception Cycles
Female 37/53 (69.8) 51/65 (78.5) 62/73 (84.9) 64/74 (86.5) 66/74 (89.2) 70/74 (94.6) 65/74 (87.8)
Male 32/53 (60.4) 42/65 (64.6) 52/73 (71.2) 58/74 (78.4) 55/74 (74.3) 48/74 (64.9) 23/74 (31.1)b
aDenominator varies due to timing of enrollment and timing of the start of the fertile window. In some cases the first day of highly fertile cervical fluid occurred
fewer than three days prior to the EDO/C and in some cases enrollment occurred fewer than three days prior to the EDO/C
bMales were instructed to discontinue collecting at Peak + 2 so specimens collected on Peak + 3 were extra
Table 5 Concurrent and retrospective questionnaire completion














Combined (n=340) 324 (95) 325 (96) 315 (93) 308 (91)
Female (n=170) 164 (96) 166 (98) 164 (96) 157 (92)
Male (n=170) 160 (94) 159 (94) 151 (89) 151 (89)
Cycle 2
Combined (n=232) 208 (90) 207 (89) 203 (88) 208 (90)
Female (n=116) 108 (93) 107 (92) 104 (90) 106 (91)
Male (n=116) 100 (86) 100 (86) 99 (85) 102 (88)
Abbreviations: EDO/C estimated day of ovulation or conception
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the woman to start urine collection, it is unclear whether
compliance among men is lower than women due to a
lack of communication between partners or if men were
aware but less motivated. Overall compliance with
completion of online concurrent and retrospective
questionnaires was high, and females consistently had
higher completion rates compared to males.
Possible approaches to obtaining urine and other bios-
pecimens in the fertile window include collecting urine
every day, which may be more resource intensive, using
fixed calendar days, which is much less accurate due to
natural variability in the fertile window [32], or using
indicators of the fertile window to target sample collec-
tion accordingly. Targeting biospecimen collection to the
fertile window has been done effectively in prior studies
using a handheld, home fertility monitor based on
urinary hormones of estrone glucuronide and luteinizing
hormone [13, 28, 33]. However, use of a fertility monitor
may be expensive for larger studies. In this study, women
identified the fertile window based on self-observation of
fertile-quality cervical fluid, supplemented and confirmed
by basal body temperature measurements [20]. This ap-
proach is inexpensive, efficient, and resulted in high
compliance in our study.
Conclusions
Our findings support a growing body of evidence sup-
porting the feasibility of successful completion of pre-
conception cohort studies for assessing environmental
exposures during the earliest critical windows of human
development around conception and implantation, with
excellent retention and high compliance of detailed ex-
posure monitoring (biospecimens and questionnaires).
Our results also confirm the emerging importance of
targeted online recruitment strategies. Our study is one
of a few that have successfully included all of the male
partners, a critical component for studying environmen-
tal impacts on fecundity and early human development.
Finally, we have demonstrated for the first time the ef-
fective implementation of a streamlined, cost-efficient
approach of women’s self-observation of fertility symp-
toms (primarily cervical fluid) applied to periconcep-
tional exposure monitoring.
Abbreviations
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